Cargando…
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the p...
Autores principales: | Petersen, Maria Skaalum, Strøm, Marin, Fjallsbak, Jógvan Páll, Hansen, Jóhanna Ljósá, Larsen, Sólrun, Eliasen, Eina H., Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Weihe, Pál |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714219/ https://www.ncbi.nlm.nih.gov/pubmed/34757895 http://dx.doi.org/10.3201/eid2801.210917 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2020) -
Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
por: Petersen, Maria Skaalum, et al.
Publicado: (2021) -
Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2022) -
SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2021) -
Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.
por: Strøm, Marin, et al.
Publicado: (2020)